TCM (570 HK): Inching Towards Regulatory Sign-Off

David has highlighted this Insight as a Top Pick
273 Views17 Sep 2024 14:58
Assuming payment late Dec, I'd buy up to ~HK$4.38/share, for a 5.0%/20% gross/annualised return. The wild card?  I'm too bullish with my timetable. And pre-cons long stop is pushed out.
What is covered in the Full Insight:
  • Recent Monthly Update
  • Regulatory Approvals Progress
  • Interim Financial Performance
  • Pre-Con Scheme and Offer Details
  • Shareholder Register and Peer Comparison
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
David Blennerhassett
Pan-Asia Catalysts/Events
Quiddity Advisors
EquitiesEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
x